| Time After Administration | ALT (U/L) | Alk P (U/L) | GGT (U/L) | Bilirubin (mg/dL) |
|---|---|---|---|---|
| Immediately before | 33 | 77 | 45 | 0.6 |
| 1st infusion | Zoledronic acid (5 mg iv), followed by fever and arthralgia | |||
| 3 days | 254 | 135 | 0.4 | |
| 6 days | 126 | 118 | 112 | 0.5 |
| 9 days | 66 | 0.7 | ||
| 1 year | 28 | 44 | 30 | 0.6 |
| 2nd infusion | Zolendronic acid (5 mg iv), followed by fever and arthralgia | |||
| 3 days (after 2nd) | 70 | 46 | 0.3 | |
| 6 days (after 2nd) | 48 | 58 | 43 | 0.4 |
| 2 years | 24 | 51 | 27 | 0.5 |
| 3rd infusion | Zolendronic acid (5 mg iv), followed by no fever or pain | |||
| 3 days (after 3rd) | 31 | 55 | 33 | 0.4 |
| Normal Values | <40 | <120 | <67 | <1.2 |
From: Bisphosphonates
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.